Stocksigma LogoStocksigma Logo

Krsnaa Diagnostics Receives In-Principle Approval for Preferential Convertible Warrants Issue

Krsnaa Diagnostics Limited received in-principle approval from BSE and NSE on 8th Oct'26 to issue 16,21,000 convertible warrants on a preferential basis to

Krsnaa Diagnostics Receives In-Principle Approval for Preferential Convertible Warrants Issue

Krsnaa Diagnostics Ltd 路 Others (Uncategorized) 路 09 Oct 2026, 3:11 am

Krsnaa Diagnostics Receives In-Principle Approval for Preferential Convertible Warrants Issue Krsnaa Diagnostics Limited received in-principle approval from BSE and NSE on 8th Oct'26 to issue 16,21,000 convertible warrants on a preferential basis to its Promoter and Promoter Group under Regulation 28(1) of SEBI LODR. Each warrant is convertible into one equity share of face value Rs. 5 each at an issue price of Rs. 566 per share, aggregating to approximately Rs. 91.75 crore. A rectified approval letter from BSE will be submitted separately due to factual errors in the initial communication.

Original exchange filing (PDF)

More announcements from Krsnaa Diagnostics Ltd

All Krsnaa Diagnostics Ltd announcements